Skip to main content

HTRF Human IL-23/IL-23R Binding Kit, 500 Assay Points

The Human IL23/IL23R binding kit is designed to identify human IL23/IL23R inhibitors.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).
Product Variants
Part number: 64BDPIL23PEG
Unit Size: 500 Assay Points
List price: USD 1,254.00
Your price:
USD 1,254.00
USD 1,254.00 /each
Part number: 64BDPIL23PEH
Unit Size: 10,000 Assay Points
List price: USD 15,010.00
Your price:
USD 0.00
USD 15,010.00 /each


IL23 is part of the response against infection, as it upregulates the expression of MMP9 (matrix metalloprotease 9), increases angiogenesis, and reduces CD8 T cell infiltration into tumors. In oncology and immuno-oncology, IL23 has been studied for its effects on T cell infiltration and its promotion on TH17 cell development. Anti IL23 antibodies have also been developed for the treatment of Crohn's Disease and psoriasis. IL23 is a heterodimeric cytokine composed of p19 and p40 subunits, and which binds the heterodimeric IL23R, IL12Rβ1 complex. The Human IL23-IL23R assay is highly specific for IL23/IL23R, and hence is especially suitable for the discovery and characterization of anti p19 antibodies.


Assay Points
Assay Target Type
Assay Technology
Shipping Conditions
Shipped in Dry Ice
Therapeutic Area
Unit Size
500 Assay Points

Video gallery

How it works

Assay principle

The HTRF IL23/IL23R Binding kit is designed to measure the interaction between IL23 and IL23R proteins. Without treatment, IL23 binds to IL23R, and the binding of each detection antibody to its respective tagged protein generates an HTRF signal. In the presence of a compound or an anti-human blocking antibody, the IL23/IL23R interaction is disrupted, and the HTRF signal decreases.



Assay Protocol

The Human IL23/IL23R binding kit can be run in 96- or 384-well low volume white plates (20 µL final). As described here, samples or standards are dispensed directly into the assay plate. The Tag1-IL23 and Tag2-IL23R proteins are then added, followed by the dispensing of the HTRF reagents: the anti Tag1 antibody labeled with europium cryptate, and  the anti Tag2 reagent labeled with d2. The reagents labeled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.



Assay validation

Inhibitory effects of IL23/IL23R blockers

The inhibitory effects of two antibodies against the p19 subunit of IL23 were tested. Guselkumab & MT155 were shown to inhibit the interaction, with both having IC50 of 2.5 nM. The anti-IL6 and anti TNFa antibodies (tocilizumab & adalimumab respectively) show no inhibition, as could be expected.

Inhibitory effect of the IL23/IL23R standard

A dose response curve for the standard using the conditions of the kit gives an IC50 of 1.6 ± 0.1 nM.



1-2 of 2 Resources
Get your autoimmunity guide

<p>A comprehensive overview of the autoimmunity world</p><p>This guide provides information on the diversity of the cell types and molecular...</p>

HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon